Vascular cognitive dysfunction is one of the common complications of cerebrovascular disease, which seriously affects the rehabilitation and quality of life of patients. Cerebrovascular diseases include hemorrhagic and ischemic cerebrovascular diseases. Traditional Chinese medicine has a unique effect in the treatment of vascular cognitive dysfunction. Howevere, the standardization of clinical trials limits the development of TCM on treatment of vascular cognitive dysfunction , such as no accepted exports or indexes applied for assessments, or no concerns about the varied exports or indexes, or high risks of the selective reported bias or lots of missing data, etc. it is necessary to establish a Core outcome set for vascular cognitive dysfunction in clinical trials of TCM.Contributors
Yunling Zhang is the principal investigator.
Xiyuan Hospital of CACMS, Beijing, China
- COS for clinical trials or clinical research
- COS for practice
- Consensus conference
- Delphi process
- Systematic review
Conduct a systematic review and interview to develop an outcome list. And then we will conduct two or three rounds of Delphi process and a consensus meeting to develop a core outcome set.